EUVIMEDEUVIMED entdecken
Crossref

Fibroblast‐driven MMP‐9/TIMP‐1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung disease

Maria Bertolotto, Daniela de Totero, Paolo Giannoni, Emanuela Barisione iD, Marco Grosso, Ennio Nano, Roberto Fiocca, Simona Pigozzi, Elisabetta Tedone, Luca Valle, Margherita Moriero, Daniela Verzola und 2 weitere

European Journal of Clinical Investigation · 2026-01 · 56 (1)

DOI: 10.1111/eci.70162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 07.12.2025. Verfasst von Maria Bertolotto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Tissue Inhibitor of Metalloproteinase-1, Matrix Metalloproteinase 9, Lung Diseases, Interstitial, Fibroblasts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Ministero dell'Università e della Ricerca, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Interstitial lung diseases (ILDs) are characterized by progressive fibrosis, in which extracellular matrix remodelling is regulated by matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). The MMP‐9/TIMP‐1 balance has been implicated in fibrogenesis, but its role in human ILD remains incompletely defined. This study aimed to assess the MMP‐9/TIMP‐1 ratio in BAL fluids of ILD patients, its relationship with fibrotic severity, and the cellular contribution of fibroblasts/myofibroblasts.

Methods

BAL samples from 48 consecutive ILD patients (non‐fibrotic ILD, fibrotic ILD, idiopathic pulmonary fibrosis [IPF]) were analysed. MMP‐9 and TIMP‐1 concentrations were quantified by enzyme‐linked immunosorbent assay (ELISA), and MMP‐9 activity assessed by gelatin zymography. Fibroblasts/myofibroblasts were isolated from BAL of ILD patients and tested for TIMP‐1 and MMP‐9 release by ELISA, or protein expression by immunofluorescence. Published single‐cell RNA sequencing datasets were reanalyzed (DESeq2 model) to define the cellular source of MMP‐9 and TIMP‐1.

Results

The MMP‐9/TIMP‐1 ratio was significantly reduced in BAL of patients with more advanced fibrosis, correlating with a higher presence of fibroblastic foci ( p = .002) and collagen deposition ( p < .001). This reduction was driven by both decreased MMP‐9 and increased TIMP‐1 levels. Zymography confirmed declining MMP‐9 enzymatic activity across ILD subgroups. Fibroblasts, derived from BAL of ILD patients, displayed high TIMP‐1 secretion but minimal MMP‐9 release, consistent with their expression in immunofluorescence. Reanalysis of two independent scRNA‐seq datasets confirmed predominant TIMP‐1 expression in fibroblast/myofibroblast clusters, with low but detectable MMP‐9 expression.

Conclusions

Fibroblast‐driven MMP‐9/TIMP‐1 imbalance in BAL reflects fibrotic severity in ILD. The MMP‐9/TIMP‐1 ratio may represent a supportive biomarker for differential diagnosis and phenotyping of ILD, warranting validation in larger multicenter studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue Inhibitor of Metalloproteinase-1Matrix Metalloproteinase 9Lung Diseases, InterstitialFibroblastsBronchoalveolar Lavage FluidIdiopathic Pulmonary FibrosisHumansMaleFemaleMiddle AgedAgedDisease ProgressionMyofibroblasts

Stichwörter der Autor:innen

extracellular matrixinterstitial lung diseasemetalloproteasispulmonary fibrosis

Substanzen

Tissue Inhibitor of Metalloproteinase-1Matrix Metalloproteinase 9TIMP1 protein, humanMMP9 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • IRCCS Ospedale Policlinico San Martino, Genoa - Italian Cardiovascular Network, Genoa, Italy.
  • Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Department of Experimental Medicine, University of Genoa, Genoa, Italy.
  • Interventional Pulmonary Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Anatomic Pathology Unit, Department of Surgical Science and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.

ORCID-Profile: Emanuela Barisione, Fabrizio Montecucco, Federico Carbone

Förderung

  • Ministero dell'Università e della Ricerca
  • Ministero della Salute

Zitieren

APA

Bertolotto, M., de Totero, D., Giannoni, P., Barisione, E., Grosso, M., Nano, E., Fiocca, R., Pigozzi, S., Tedone, E., Valle, L., Moriero, M., Verzola, D., Montecucco, F., & Carbone, F. (2026). Fibroblast‐driven MMP‐9/TIMP‐1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung disease. European Journal of Clinical Investigation, 56(1). https://doi.org/10.1111/eci.70162

Vancouver

Bertolotto M, de Totero D, Giannoni P, Barisione E, Grosso M, Nano E, et al. Fibroblast‐driven MMP‐9/TIMP‐1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung disease. European Journal of Clinical Investigation. 2026;56(1). doi:10.1111/eci.70162

BibTeX
@article{Bertolotto2026,
  author = {Bertolotto, Maria and de Totero, Daniela and Giannoni, Paolo and Barisione, Emanuela and Grosso, Marco and Nano, Ennio and Fiocca, Roberto and Pigozzi, Simona and Tedone, Elisabetta and Valle, Luca and Moriero, Margherita and Verzola, Daniela and Montecucco, Fabrizio and Carbone, Federico},
  title = {Fibroblast‐driven MMP‐9/TIMP‐1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung disease},
  journal = {European Journal of Clinical Investigation},
  year = {2026},
  volume = {56},
  number = {1},
  doi = {10.1111/eci.70162}
}
Kostenlos starten →